Back to Tom Steyer
Tom Steyer → TMO via FARALLON CAPITAL MANAGEMENT, L.L.C.
Tom Steyer TMO Position History
Thermo Fisher Scientific Inc. • Healthcare
Quarters held
15
Latest value
$526M
Q2 2026
Peak value
$648.9M
First seen
Q2 2023
Quarter-by-quarter history
Every disclosed snapshot
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $526M | 1.05M | — | — |
| Q1 2026 | $433.3M | 881.5K | — | — |
| Q4 2025 | $368.3M | 635.7K | — | — |
| Q3 2025 | $610.3M | 1.26M | — | — |
| Q3 2025 | $610.3M | 1.26M | — | — |
| Q2 2025 | $560.8M | 1.38M | — | — |
| Q1 2025 | $515.4M | 1.04M | — | — |
| Q4 2024 | $641.6M | 1.23M | — | — |
| Q3 2024 | $438.8M | 709.5K | — | — |
| Q2 2024 | $408.8M | 739.2K | — | — |
| Q1 2024 | $463.5M | 797.4K | — | — |
| Q1 2024 | $463.5M | 797.4K | — | — |
| Q4 2023 | $638.6M | 1.20M | — | — |
| Q3 2023 | $530.2M | 1.05M | — | — |
| Q2 2023 | $648.9M | 1.24M | — | — |